Menu

Close

Pioneering memory studies. Providing hope for Alzheimer’s disease.

Re:Cognition Health is changing  the future for those with memory loss and other symptoms of cognitive impairment.

With more than 140,000 people living with a diagnosis of mild cognitive impairment or dementia in Virginia, we aim to support individuals with memory loss and other symptoms of cognitive impairment through providing education, clinical excellence and access to the most advanced treatments available worldwide.

Register by clicking here

We know that early diagnosis is key for the management of symptoms. But what are the other potential benefits of participation? 

  • Access new-generation medications that are designed to delay the progression of Alzheimer’s disease, for free

  • Comprehensive healthcare at no cost to the volunteer

  • Reimbursement of travel expenses

  • Contribute to the development of a cure for Alzheimer’s disease 

  • Help us to provide hope for Alzheimer’s disease 

More than 140,000 people are living with a diagnosis of mild cognitive impairment or dementia in Virginia

Patient welfare is at the heart of everything we do

Our expert team are here to support you every step of the way. Our patient-centred approach means that everything we do is in the best interests of each of our patients.

We are recognised as a global-leader in enrolling volunteers onto ground-breaking memory studies and are committed to providing world-leading medical care to all of our patients.

To learn more about our cognitive healthcare program, please call our dedicated team via

703-520-9703

Register by clicking here

The Re:Cognition Health Fairfax Clinic is located at:

8316 Arlington Boulevard, Suite 420 Fairfax, VA 22031

You can reach us via:

703-520-9703

clinician@re-cognitionhealth.com

 

 

 

 

 

 

Send us a message by filling in the form below

Frequently Asked Questions

Q) Will I be paid?

A) You will not be paid for your participation in the clinical trial, however, the sponsor will reimburse reasonable travel expenses for you and your study partner for each visit.

Q) What is a study partner and why do I need one?

A) A study partner is someone who can accompany the participant to some study visits and answer questions about their symptoms. They should be someone who sees the volunteer regularly e.g. a spouse, relative or close friend as they will need to let us know about any potential changes in the volunteer’s health or behaviour. The number of visits they need to attend depends on each study.

Q) How often are the visits?

A) The frequency of the visits will depend on the clinical trial that you participate in. The trials will have a period of frequent visits at the start during the screening period. The screening period is when all the initial investigations are carried out to establish whether an individual is eligible for the trial. During the treatment stage of the study, the visits will be less frequent. Some trials require a clinic visit once a month whereas others have visits every six 6 weeks. Once you are on a trial, we will be able to give you all your appointments in advance.

Q) Can I leave the trial before it finishes?

A) You can leave the trial at any point. Your medical or legal rights will not be affected. You do not need to give a reason as to why you want to leave, although we always value any feedback from you. If you choose to leave after you have started taking the trial drug, then we are obliged to offer you a final visit, called the termination visit.

Q) I have vascular dementia, can I take part?

A) No. All of our current clinical trials are for Alzheimer’s Disease. However, we are always investigating new studies so please register your contact details and we will get in touch when we have a trial that is suitable for you.

Q) Will I get my results?

A) As part of the trial, you will undergo various screening tests. These include a medical examination, blood pressure reading, urine tests, ECG, MRI head scan, a PET scan or lumbar puncture. You will be informed of all of you results and GP will also be made aware of any significant results.

Q) Will I have to take a trial drug?

A) Yes. If you are found to be eligible for one of the clinical trials, then you can consent to be assigned to a treatment group. Depending on the trial, the trial medication can be in the form of a tablet taken orally once a day or an intravenous infusion once a month.

Q) Will I know what I am taking?

A) No. You will not know whether you are taking the active study drug or a placebo. A placebo is a dummy pill and does not contain any active drug. You will be randomly assigned into one of the study groups and you and your study team will not know which group you are in. This is called a randomised, double-blind, placebo controlled trial.

Q) What if I am on placebo?

A) There is a chance that you are in the placebo group, the probability of that will depend on the trial. It may be anyway between 1:2 to 1:3. Whichever group you are in, you will still benefit from the ongoing medical care and psychometric testing that you will receive as part of the trial. At the end of the trial period, most trials offer the opportunity for you to enter the open label extension. This is when you continue in the trial but on the active drug despite whichever group (ie. Placebo or active drug) group you were in before. The open label extension is un-blinded, so you will know you are on the active drug.

Q) Are there any side effects?

A) Any potential side effects will be listed in the patient information sheets that are sent to you prior to your initial consultation. Most of the side effects are non-specific but some trials have specific side effects that your study doctor will discuss with you. We will work closely with you and your GP to ensure your safety at all times.

A) Re:Cognition Health is located at 8316 Arlington Boulevard, Suite 420, Fairfax, VA, 22031